Nevada
SB377
SB377 - Establishes provisions relating to health insurance. (BDR 57-1083)
Source: LegiScan ·
7,227 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
S.B. 377
-
*SB377*
SENATE BILL NO. 377–SENATOR STEINBECK
MARCH 17, 2025
____________
Referred to Committee on Commerce and Labor
SUMMARY—Establishes provisions relating to health insurance.
(BDR 57-1083)
FISCAL NOTE: Effect on Local Government: May have Fiscal Impact.
Effect on the State: Yes.
CONTAINS UNFUNDED MANDATE (§ 13)
(NOT REQUESTED BY AFFECTED LOCAL GOVERNMENT)
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to insurance; requiring certain policies of health
insurance to include coverage for certain alternatives to
opioids; and providing other matters properly relating
thereto.
Legislative Counsel’s Digest:
Existing law requires public and private policies of insurance regulated under
1
Nevada law and employers who provide such insurance for their employees to
2
include coverage for drugs to: (1) support safe withdrawal from substance use
3
disorder; and (2) provide medication-assisted treatment for opioid use disorder.
4
(NRS 287.010, 287.04335, 422.4025, 608.1555, 689A.0459, 689B.0319,
5
689C.1665, 695A.1874, 695B.19197, 695C.050, 695C.1699, 695G.1719) Sections
6
2, 4-10 and 12-15 of this bill require certain public and private policies of health
7
insurance to cover drugs that are alternatives to opioids for purposes for which
8
opioids are commonly used. Sections 1, 2, 4-10, 12-14 and 16 of this bill: (1)
9
prohibit certain insurers from imposing certain other conditions on covered opioid
10
alternatives that are not imposed on opioids; and (2) require such an insurer to
11
exempt an insured from medical management techniques that would otherwise
12
apply to an alternative to an opioid if the provider of health care prescribing or
13
administering the alternative confirms that the alternative is an appropriate
14
treatment for the patient. Section 3 of this bill authorizes the Commissioner of
15
Insurance to require certain policies of health insurance issued by a domestic
16
insurer to a person who resides in another state to include the coverage required by
17
section 2. Section 11 of this bill authorizes the Commissioner to suspend or revoke
18
the certification of a health maintenance organization that fails to comply with the
19
requirements of section 9. The Commissioner would also be authorized to take
20
such actions against other health insurers who fail to comply with the requirements
21
of sections 2, 4-10 and 12. (NRS 680A.200)
22
– 2 –
-
*SB377*
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
Section 1. NRS 687B.225 is hereby amended to read as
1
follows:
2
687B.225 1. Except
as
otherwise
provided
in
NRS
3
689A.0405, 689A.0412, 689A.0413, 689A.0418, 689A.0437,
4
689A.044,
689A.0445,
689A.0459,
689B.031,
689B.0312,
5
689B.0313, 689B.0315, 689B.0317, 689B.0319, 689B.0374,
6
689B.0378, 689C.1665, 689C.1671, 689C.1675, 689C.1676,
7
695A.1843, 695A.1856, 695A.1865, 695A.1874, 695B.1912,
8
695B.1913, 695B.1914, 695B.1919, 695B.19197, 695B.1924,
9
695B.1925, 695B.1942, 695C.1696, 695C.1699, 695C.1713,
10
695C.1735, 695C.1737, 695C.1743, 695C.1745, 695C.1751,
11
695G.170,
695G.1705,
695G.171,
695G.1714,
695G.1715,
12
695G.1719 and 695G.177, and sections 2, 4, 5, 7, 8, 9 and 12 of
13
this act, any contract for group, blanket or individual health
14
insurance or any contract by a nonprofit hospital, medical or dental
15
service corporation or organization for dental care which provides
16
for payment of a certain part of medical or dental care may require
17
the insured or member to obtain prior authorization for that care
18
from the insurer or organization. The insurer or organization shall:
19
(a) File its procedure for obtaining approval of care pursuant to
20
this section for approval by the Commissioner; and
21
(b) Unless a shorter time period is prescribed by a specific
22
statute, including, without limitation, NRS 689A.0446, 689B.0361,
23
689C.1688, 695A.1859, 695B.19087, 695C.16932 and 695G.1703,
24
respond to any request for approval by the insured or member
25
pursuant to this section within 20 days after it receives the request.
26
2. The procedure for prior authorization may not discriminate
27
among persons licensed to provide the covered care.
28
Sec. 2. Chapter 689A of NRS is hereby amended by adding
29
thereto a new section to read as follows:
30
1. An insurer that offers or issues a policy of health
31
insurance shall include in the policy coverage for at least one
32
alternative to an opioid that is effective for each purpose for
33
which:
34
(a) An opioid is commonly used; and
35
(b) A non-opioid alternative is available.
36
2. An insurer shall not:
37
(a) Require prior authorization for an alternative to an opioid
38
if prior authorization would not be required for an opioid under
39
the same circumstances; or
40
– 3 –
-
*SB377*
(b) Impose other requirements on an alternative to an opioid
1
that would not be imposed on an opioid used under the same
2
circumstances.
3
3. An insurer shall exempt an insured from any medical
4
management techniques that would otherwise apply to the benefits
5
described in subsection 1 if the provider of health care who
6
prescribes or administers an alternative to an opioid confirms that,
7
in the professional judgment of the provider of health care, the
8
alternative to an opioid is appropriate for the treatment of the
9
patient.
10
4. A policy of health insurance subject to the provisions of
11
this chapter that is delivered, issued for delivery or renewed on or
12
after January 1, 2026, has the legal effect of including the
13
coverage required by subsection 1, and any provision of the policy
14
that conflict with the provisions of this section is void.
15
5. As used in this section:
16
(a) “Medical management technique” means a practice which
17
is used to control the cost or utilization of health care services or
18
prescription drug use. The term includes, without limitation, the
19
use of step therapy, prior authorization or categorizing drugs and
20
devices based on cost, type or method of administration.
21
(b) “Provider of health care” has the meaning ascribed to it in
22
NRS 629.031.
23
Sec. 3. NRS 689A.330 is hereby amended to read as follows:
24
689A.330 If any policy is issued by a domestic insurer for
25
delivery to a person residing in another state, and if the insurance
26
commissioner or corresponding public officer of that other state has
27
informed the Commissioner that the policy is not subject to approval
28
or disapproval by that officer, the Commissioner may by ruling
29
require that the policy meet the standards set forth in NRS 689A.030
30
to 689A.320, inclusive [.] , and section 2 of this act.
31
Sec. 4. Chapter 689B of NRS is hereby amended by adding
32
thereto a new section to read as follows:
33
1. An insurer that offers or issues a policy of group health
34
insurance shall include in the policy coverage for at least one
35
alternative to an opioid that is effective for each purpose for
36
which:
37
(a) An opioid is commonly used; and
38
(b) A non-opioid alternative is available.
39
2. An insurer shall not:
40
(a) Require prior authorization for an alternative to an opioid
41
if prior authorization would not be required for an opioid under
42
the same circumstances; or
43
– 4 –
-
*SB377*
(b) Impose other requirements on an alternative to an opioid
1
that would not be imposed on an opioid used under the same
2
circumstances.
3
3. An insurer shall exempt an insured from any medical
4
management techniques that would otherwise apply to the benefits
5
described in subsection 1 if the provider of health care who
6
prescribes or administers an alternative to an opioid confirms that,
7
in the professional judgment of the provider of health care, the
8
alternative to an opioid is appropriate for the treatment of the
9
patient.
10
4. A policy of group health insurance subject to the
11
provisions of this chapter that is delivered, issued for delivery or
12
renewed on or after January 1, 2026, has the legal effect of
13
including the coverage required by subsection 1, and any
14
provisions of the policy that conflict with the provisions of this
15
section is void.
16
5. As used in this section:
17
(a) “Medical management technique” means a practice which
18
is used to control the cost or utilization of health care services or
19
prescription drug use. The term includes, without limitation, the
20
use of step therapy, prior authorization or categorizing drugs and
21
devices based on cost, type or method of administration.
22
(b) “Provider of health care” has the meaning ascribed to it in
23
NRS 629.031.
24
Sec. 5. Chapter 689C of NRS is hereby amended by adding
25
thereto a new section to read as follows:
26
1. A carrier that offers or issues a health benefit plan shall
27
include in the plan coverage for at least one alternative to an
28
opioid that is effective for each purpose for which:
29
(a) An opioid is commonly used; and
30
(b) A non-opioid alternative is available.
31
2. A carrier shall not:
32
(a) Require prior authorization for an alternative to an opioid
33
if prior authorization would not be required for an opioid under
34
the same circumstances; or
35
(b) Impose other requirements on an alternative to an opioid
36
that would not be imposed on an opioid used under the same
37
circumstances.
38
3. A carrier shall exempt an insured from any medical
39
management techniques that would otherwise apply to the benefits
40
described in subsection 1 if the provider of health care who
41
prescribes or administers an alternative to an opioid confirms that,
42
in the professional judgment of the provider of health care, the
43
alternative to an opioid is appropriate for the treatment of the
44
patient.
45
– 5 –
-
*SB377*
4. A health benefit plan subject to the provisions of this
1
chapter that is delivered, issued for delivery or renewed on or after
2
January 1, 2026, has the legal effect of including the coverage
3
required by subsection 1, and any provisions of the plan that
4
conflict with the provisions of this section is void.
5
5. As used in this section:
6
(a) “Medical management technique” means a practice which
7
is used to control the cost or utilization of health care services or
8
prescription drug use. The term includes, without limitation, the
9
use of step therapy, prior authorization or categorizing drugs and
10
devices based on cost, type or method of administration.
11
(b) “Provider of health care” has the meaning ascribed to it in
12
NRS 629.031.
13
Sec. 6. NRS 689C.425 is hereby amended to read as follows:
14
689C.425 A voluntary purchasing group and any contract
15
issued to such a group pursuant to NRS 689C.360 to 689C.600,
16
inclusive, are subject to the provisions of NRS 689C.015 to
17
689C.355, inclusive, and section 5 of this act, to the extent
18
applicable and not in conflict with the express provisions of NRS
19
687B.408 and 689C.360 to 689C.600, inclusive.
20
Sec. 7. Chapter 695A of NRS is hereby amended by adding
21
thereto a new section to read as follows:
22
1. A society that offers or issues a benefit contract shall
23
include in the contract coverage for at least one alternative to an
24
opioid that is effective for each purpose for which:
25
(a) An opioid is commonly used; and
26
(b) A non-opioid alternative is available.
27
2. A society shall not:
28
(a) Require prior authorization for an alternative to an opioid
29
if prior authorization would not be required for an opioid under
30
the same circumstances; or
31
(b) Impose other requirements on an alternative to an opioid
32
that would not be imposed on an opioid used under the same
33
circumstances.
34
3. A society shall exempt an insured from any medical
35
management techniques that would otherwise apply to the benefits
36
described in subsection 1 if the provider of health care who
37
prescribes or administers an alternative to an opioid confirms that,
38
in the professional judgment of the provider of health care, the
39
alternative to an opioid is appropriate for the treatment of the
40
patient.
41
4. A benefit contract subject to the provisions of this chapter
42
that is delivered, issued for delivery or renewed on or after
43
January 1, 2026, has the legal effect of including the coverage
44
– 6 –
-
*SB377*
required by subsection 1, and any provisions of the contract that
1
conflict with the provisions of this section is void.
2
5. As used in this section:
3
(a) “Medical management technique” means a practice which
4
is used to control the cost or utilization of health care services or
5
prescription drug use. The term includes, without limitation, the
6
use of step therapy, prior authorization or categorizing drugs and
7
devices based on cost, type or method of administration.
8
(b) “Provider of health care” has the meaning ascribed to it in
9
NRS 629.031.
10
Sec. 8. Chapter 695B of NRS is hereby amended by adding
11
thereto a new section to read as follows:
12
1. A hospital or medical services corporation that offers or
13
issues a policy of health insurance shall include in the policy
14
coverage for at least one alternative to an opioid that is effective
15
for each purpose for which:
16
(a) An opioid is commonly used; and
17
(b) A non-opioid alternative is available.
18
2. A hospital or medical services corporation shall not:
19
(a) Require prior authorization for an alternative to an opioid
20
if prior authorization would not be required for an opioid under
21
the same circumstances; or
22
(b) Impose other requirements on an alternative to an opioid
23
that would not be imposed on an opioid used under the same
24
circumstances.
25
3. A hospital or medical services corporation shall exempt an
26
insured from any medical management techniques that would
27
otherwise apply to the benefits described in subsection 1 if the
28
provider of health care who prescribes or administers an
29
alternative to an opioid confirms that, in the professional
30
judgment of the provider of health care, the alternative to an
31
opioid is appropriate for the treatment of the patient.
32
4. A policy of health insurance subject to the provisions of
33
this chapter th
[Text truncated for display. Full text available on LegiScan.]
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on LegiScan
or a qualified attorney for legal matters.